<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00850720</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00007443</org_study_id>
    <nct_id>NCT00850720</nct_id>
  </id_info>
  <brief_title>Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants</brief_title>
  <official_title>Prevalence of Neuroendocrine Dysfunction in the Pediatric Cardiopulmonary Bypass Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Healthcare of Atlanta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate specific hormone levels in children undergoing heart
      surgery in order to identify patterns associated with any unstable vital signs. The data
      collected will provide preliminary answers to the question &quot;Are hormone values a determining
      factor for drug administration and dosing levels?&quot; and help establish the benefits of routine
      steroid and hormone administration. Sixty subjects will be enrolled. Blood samples will be
      drawn before the surgery,and again nine hours after surgery for analysis. Other patient data
      such as medications, vital signs, routine lab values and treatments will also be analyzed. As
      our current standard of care includes routine doses of steroids, we believe this study will
      increase our general knowledge and improve the care of these critically ill children. The
      study will also provide the foundation needed for grant support from the American Heart
      Association, allowing for future larger scale studies.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Inability to recruit / logistic problems.
  </why_stopped>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NO Outcomes - Study Terminated Without Data.</measure>
    <time_frame>Study terminated - no data.</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Cardiac Surgery</arm_group_label>
    <description>Infants with congenital defects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood draws</intervention_name>
    <description>Samples of blood to be drawn before surgery, and nine hours after surgery.</description>
    <arm_group_label>Cardiac Surgery</arm_group_label>
    <other_name>Tests being analyzed:</other_name>
    <other_name>• Cortisol</other_name>
    <other_name>• Vasopressin (ADH)</other_name>
    <other_name>• Cortisol Free</other_name>
    <other_name>• Thyroid Stimulating Hormone (TSH)</other_name>
    <other_name>• Free Thyroxine(FT4)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients at Childrens Healthcare of Atlanta at Egleston
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with congenital heart disease requiring cardiopulmonary bypass(CPB) surgery
             less than 1 year of age admitted to the cardiac intensive care unit (CICU)
             preoperatively, who required blood sampling as part of their care.

          -  Subject must have arterial or central venous lines to be enrolled.

          -  Subject must have a documented weight of 2.5 Kilograms or greater.

          -  Subjects' legal guardian shall possess the ability to understand the purposes and
             risks of the study and provide an informed consent signature.

        Exclusion Criteria:

          -  Medical urgency preventing timely administration of the consenting process.

          -  Any condition that, in the opinion of the attending physician, would place the patient
             at undue risk by participating. Specific conditions might include, but are not limited
             to, anemia or coagulopathy.

          -  Have given steroids intravenously (IV) or oral steroids within the last month.

          -  Have a preexisting neuroendocrine disorder.

          -  Have been treated with antipsychotic medication.

          -  Have human immunodeficiency virus (HIV).

          -  Have received etomidate for intubation.

          -  Other technical considerations that would prevent acquisition of sufficient samples OR
             inability / unwillingness of the legal guardian to provide consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kiran Hebbar, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University &amp; Children's Healthcare of Atlanta</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta at Egleston</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2009</study_first_submitted>
  <study_first_submitted_qc>February 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2009</study_first_posted>
  <results_first_submitted>January 15, 2010</results_first_submitted>
  <results_first_submitted_qc>November 18, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 7, 2014</results_first_posted>
  <last_update_submitted>November 18, 2013</last_update_submitted>
  <last_update_submitted_qc>November 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Kiran Hebbar</investigator_full_name>
    <investigator_title>Assistant Professor - CT</investigator_title>
  </responsible_party>
  <keyword>Biological Response Modifiers</keyword>
  <keyword>Bypass Surgery</keyword>
  <keyword>Cardiology</keyword>
  <keyword>Congenital Heart Disease</keyword>
  <keyword>Endocrinology</keyword>
  <keyword>Hormone Dysfunction</keyword>
  <keyword>Hormones</keyword>
  <keyword>Neuroendocrinology</keyword>
  <keyword>Pediatric Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Cardiac Surgery</title>
          <description>Infants with congenital defects.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cardiac Surgery</title>
          <description>Infants with congenital defects.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
          </count_list>
        </analyzed>
      </analyzed_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>NO Outcomes - Study Terminated Without Data.</title>
        <time_frame>Study terminated - no data.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cardiac Surgery</title>
            <description>Infants with congenital defects.</description>
          </group>
        </group_list>
        <measure>
          <title>NO Outcomes - Study Terminated Without Data.</title>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Cardiac Surgery</title>
          <description>Infants with congenital defects.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination of study; Technical problems with measurement leading to unreliable or uninterpretable data.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Kiran Hebbar, MBBS</name_or_title>
      <organization>Children's Healthcare of Atlanta</organization>
      <phone>404-785-1600</phone>
      <email>kiran.hebbar@choa.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

